Herborium Group, Inc. is an international natural therapeutics company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company’s business model focuses on emerging opportunities spearheaded by the growth of new markets located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). Herborium offers products for dermatological conditions, wellness and energy, women’s health, selected sexual disorders, and specialty offerings.
Analyst Expects Massive Upside In Herborium Group Stock (HBRM)
